LabCompass

Huda Salman

Medicine · Indiana University

OpenAlex ORCID
CAR-T cell therapy researchAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationImmune Cell Function and InteractionAnalytical Methods in Pharmaceuticals

Publications

60

Citations

955

Est. group size

—

Recurring co-author estimate

Active years

23

Publishing since 2003

Research summary
AI-generated

This researcher works on cancer immunotherapy, focusing on engineering CAR-T cells (immune cells modified in the lab to recognize and attack cancer) to treat blood cancers such as acute myeloid leukemia, B-cell leukemias, and lymphomas. The work spans laboratory design of new cell therapies as well as clinical trials of drugs for relapsed blood cancers.

CAR-T cell therapy engineeringAcute myeloid leukemiaB-cell leukemias and lymphomasHematopoietic stem cells and blood cell developmentClinical trials for blood cancers

Publication activity has been growing, rising from a few papers per year in the late 2010s to its highest output in 2024-2025.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 5.2/year recently
2017: 2 publications172018: 3 publications182019: 5 publications192020: 4 publications202021: 3 publications212022: 5 publications222023: 4 publications232024: 7 publications242025: 10 publications102526
Recent publications
Publishes in
  • Oncotarget×3
  • Blood×3
  • Molecular Therapy×2
  • Cells×2
  • Leukemia Research Reports×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile